This management is particularly possible in type 2 diabetes patients with somewhat reserved endogenous insulin secretory capacity, as with the case management of alcoholic ketoacidosis, a sub-type of euglycemic ketoacidosis. The gene discussed is INS; the disease is type 2 diabetes mellitus.